Diagnostic test for cervical cancer, where a cervical cancer tissue is probed for a specific polypeptide using a specific monoclonal antibody.
US 20050142620
Facts from the Community
From the BioVenturist base
Assignee:
Priority application date:
- Aug 19, 2004
Publication date:
- Jun 30, 2005
Technology involved:
Application status:
Patent number:
- US 20050142620
Disease involved:
You can help improve this topic by adding more facts here
